CRYSTAL BAKER: Open Payments
NPI 1144428541 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 27 payments from 10 companies in 2025. Trend: 2023 $510 · 2024 $606 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $173 |
| ABBVIE INC. | 6 | $117 |
| Novo Nordisk Inc | 5 | $101 |
| PFIZER INC. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Lilly USA, LLC | 2 | $39 |
| Amgen Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, REXULTI, ELIQUIS, VRAYLAR, Ozempic, Wegovy, MOUNJARO, UBRELVY.
Industry payments across NY — which companies pay providers there.
